https://doi.org/10.4081/hmr.v1i5.245

Immunosuppression and lymphomagenesis

Vol. 1 No. 5: International Symposium on Infection-Driven Lymphomas, Rome, April 17-19, 2005
Published: May 29, 2009
Abstract Views: 152
Untitled (): 0
PDF: 119
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Amy Chadburn
support@pagepress.org
Individuals who are immunosuppressed are at an increased risk for developing aggressive, primarily B cell, lymphoproliferative disorders/lymphomas (LPDs). There are four clinical settings recognized by the WHO classification which are associated with development of LPDs: (1) primary immune disorders, (2) HIV infection, (3) iatrogenic immunosuppression following solid organ or allogenic bone marrow transplantation and (4) methotrexate therapy, usually for an autoimmune disorder. The diagnosis of LPDs is often problematic and the prognosis of the patients difficult to predict. 

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Chadburn, A. (2009). Immunosuppression and lymphomagenesis. Hematology Meeting Reports (formerly Haematologica Reports), 1(5). https://doi.org/10.4081/hmr.v1i5.245
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).